Research Grants

Grant Funding for Pharmacist-Led Cancer Research

HOPA research grants provide support for projects that are likely to result in facilitating the efforts of hematology/oncology pharmacists to optimize the care of individuals affected by cancer.

HOPA Research Fund Award

Submit your Letter of Intent today!

The Research Fund Award (RFA) supports pharmacist-led research in the areas of clinical or patient outcomes, patient safety, standards validation/benchmarking, and basic/translational science.

Projects should align closely with the HOPA strategic imperative to support pharmacist-led research that advances patient care and the profession itself.

How to Submit your Research Grant Proposal

Those interested in applying for the HOPA Research Fund Award must first submit a Letter of Intent (LOI) by Tuesday, July 15, 2025 at 11:59 p.m. EST. For more information on requirements for the LOI as well as specifics for your letter's organization and key elements, click here.

The LOIs will be evaluated by the HOPA Research and Grant Reviewers Committee, and submission of full applications will be invited for eligible projects. Decisions from the HOPA Research and Grant Reviewers Committee will be communicated to the candidates by August 2025. Those invited to submit a full proposal will need to do so by November 3rd, 2025.

Click here to get started and submit your Letter of Intent!

To prepare your full proposal, use Grant Application PHS 398 instructions and forms from the US Department of Health and Human Services. Access those here:

Application for Public Health Services Grants

Grant Proposal Criteria

Single or multiple institutions may apply
Projects with co-PIs are allowed
PI or co-PI must be an active HOPA member

Funding Available

Up to $100,000 will be awarded to up to three chosen applicants through a competitive peer-review process. HOPA aims to fund at least one practice-based/clinical and one basic/translational study each year.

Research Areas Accepted

Clinical or patient outcomes
Surveys
Patient safety
Standards validation/benchmarking
Basic/translational science

A subsequent publication resulting from the research project is expected within a year of study completion. In addition, the awardee is expected to present the results of their research at the HOPA Annual Conference. The presentation is expected to occur no later than two years after the release of the research funds, Annual Conference presentation slots allow.

Questions? The HOPA Research Grant Reviewers Committee has prepared the full Request for Research Proposal details.

You can also contact the HOPA Education team directly.

Listen to Alexandre Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, AP, explain the importance of HOPA research grants:

Early Career Research Grant

Applications are currently closed.

The Early Career Research Grant (ECRG) provides funding to promising investigators early in your career to encourage and promote quality, basic, and pre-clinical translational lab-based research. You are also encouraged to pursue clinical or patient-focused research in hematology/oncology pharmacy.

The purpose of this award is to fund U.S.-based pharmacists within their first 7 years post completion of formal training and have not yet attained R21 (NIH Exploratory/Developmental Research Grant Award) level funding.

Awarded early career pharmacists will be required to work with a mentor either from their sponsoring institution or to find a mentor from another institution within the United States. The PI of the proposal must also be an active HOPA member.

The Early Career Research Grant will award up to $50,000 to one or two chosen applicants through a competitive peer-review process.

HOPA's call for proposals opens in the winter and grants are awarded the following spring.

How to apply

Please follow the specific formatting and submission instructions: Early Career Research Grant Info
Contact the HOPA Education team with questions at education@hoparx.org